Cray Decision May Set Back Future Work

WASHINGTON---The decision by Cray Research Inc. to abandon development of its most advanced supercomputer project has dealt a blow to the U.S. supercomputer industry and may set back researchers in the 1990s, say some specialists in the field. “I think the United States has lost one of its very serious efforts in supercomputing,” said Lawrence Lee, director of the Cornell National Supercomputer Facility in Ithaca, N.Y, who added that the step may have “serious repercussion

Written byStephen Greene
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

WASHINGTON---The decision by Cray Research Inc. to abandon development of its most advanced supercomputer project has dealt a blow to the U.S. supercomputer industry and may set back researchers in the 1990s, say some specialists in the field.

“I think the United States has lost one of its very serious efforts in supercomputing,” said Lawrence Lee, director of the Cornell National Supercomputer Facility in Ithaca, N.Y, who added that the step may have “serious repercussions” as the nation tries to maintain its lead in this area.

Cray announced September 2 that it had canceled its MP (for multiple processing) computer design project headed by Steve S. Chen, which was proving costlier and more complicated than expected. Cray said Chen would try to develop the supercomputer on his own.

That news is “a little worrying, not for scientists today but for scientists about five years from now,” said John Connolly, director ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies